Pharma Stock in Focus After Agreement to Acquire Remaining 12% Stake in Its Subsidiary
A pharmaceutical company is making headlines after announcing a Rs. 231.87 crore acquisition to take full ownership of its biologics subsidiary, aiming to bolster its biotechnology sector.